• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫颈癌的组织学分级与预后

Histologic grade and prognosis of carcinoma of the cervix.

作者信息

Chung C K, Stryker J A, Ward S P, Nahhas W A, Mortel R

出版信息

Obstet Gynecol. 1981 May;57(5):636-42.

PMID:7219913
Abstract

A histologic grading system based on tumor differentiation was applied in a study of 122 patients with stage IB and IIA squamous cell carcinoma of the uterine cervix. In general, the more dedifferentiated the primary tumor, the more bulky the primary lesion and the higher the incidence of pelvic node metastasis. Following treatment, patients with undifferentiated tumors had a higher incidence of tumor recurrence a lower 2-year survival rate than those with well or moderately differentiated lesions. These findings suggest that histologic grading is an important adjunct to the clinical evaluation of cervical cancer.

摘要

在一项针对122例子宫颈IB期和IIA期鳞状细胞癌患者的研究中,应用了基于肿瘤分化的组织学分级系统。一般来说,原发性肿瘤的分化程度越低,原发性病变越大,盆腔淋巴结转移的发生率越高。治疗后,未分化肿瘤患者的肿瘤复发率较高,2年生存率低于高分化或中分化病变患者。这些发现表明,组织学分级是宫颈癌临床评估的重要辅助手段。

相似文献

1
Histologic grade and prognosis of carcinoma of the cervix.子宫颈癌的组织学分级与预后
Obstet Gynecol. 1981 May;57(5):636-42.
2
Adenosquamous carcinoma of the cervix: prognosis in stage IB.
Obstet Gynecol. 1990 Jun;75(6):1012-5.
3
A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.子宫颈病理I b期腺癌与鳞状细胞癌预后的比较。
Gynecol Oncol. 2000 Nov;79(2):289-93. doi: 10.1006/gyno.2000.5935.
4
[Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].[血清鳞状细胞癌抗原与子宫颈鳞状细胞癌临床病理特征及预后的相关性]
Zhonghua Fu Chan Ke Za Zhi. 2007 Jan;42(1):29-33.
5
Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.肿瘤标志物癌胚抗原(CEA)、组织多肽抗原(TPA)和鳞状细胞癌抗原(SCC-Ag)在国际妇产科联盟(FIGO)低风险IB期和IIA期子宫颈鳞状细胞癌患者中的应用。
Gynecol Oncol. 2000 Jan;76(1):103-6. doi: 10.1006/gyno.1999.5665.
6
Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.伴有不良预后因素的IB-IIB期宫颈癌的术后放射治疗。
Anticancer Res. 2000 May-Jun;20(3B):2235-9.
7
The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.早期宫颈癌患者行根治性子宫切除术后放疗的预后因素。
Gynecol Oncol. 1999 Dec;75(3):328-33. doi: 10.1006/gyno.1999.5527.
8
Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma.肿瘤大小、浸润深度以及浸润性肿瘤前沿的分级是早期宫颈鳞状细胞癌的主要预后因素。
Gynecol Oncol. 1999 Aug;74(2):245-51. doi: 10.1006/gyno.1999.5420.
9
Missing association between telomerase activity and clinicopathological features in patients with early stage carcinoma of the cervix.早期宫颈癌患者中端粒酶活性与临床病理特征之间不存在相关性。
Arch Gynecol Obstet. 2007 Jan;275(1):13-7. doi: 10.1007/s00404-006-0206-3. Epub 2006 Jul 21.
10
An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.一项关于手术分期为IB期宫颈癌患者细胞类型的分析:妇科肿瘤学组研究
Gynecol Oncol. 1996 Dec;63(3):304-11. doi: 10.1006/gyno.1996.0327.

引用本文的文献

1
Downregulation of and its prognostic significance in squamous cell carcinoma of the cervix: a bioinformatics analysis based on public datasets.在子宫颈鳞状细胞癌中[具体基因或因子名称]的下调及其预后意义:基于公共数据集的生物信息学分析
Transl Cancer Res. 2025 Jul 30;14(7):4034-4045. doi: 10.21037/tcr-2025-307. Epub 2025 Jul 25.
2
Enhancing prognostic accuracy: a SEER-based analysis for overall and cancer-specific survival prediction in cervical adenocarcinoma patients.提高预后准确性:基于 SEER 的分析用于预测宫颈腺癌患者的总体和癌症特异性生存。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17027-17037. doi: 10.1007/s00432-023-05399-2. Epub 2023 Sep 25.
3
Prognostic Model for Predicting Overall and Cancer-Specific Survival Among Patients With Cervical Squamous Cell Carcinoma: A SEER Based Study.
预测宫颈鳞状细胞癌患者总生存和癌症特异性生存的预后模型:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Oncol. 2021 Jul 14;11:651975. doi: 10.3389/fonc.2021.651975. eCollection 2021.
4
Texture analysis versus conventional MRI prognostic factors in predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced cancer of the uterine cervix.纹理分析与传统 MRI 预后因素在预测局部晚期宫颈癌新辅助化疗肿瘤反应中的比较。
Radiol Med. 2019 Oct;124(10):955-964. doi: 10.1007/s11547-019-01055-3. Epub 2019 Jun 28.
5
Association of tumor differentiation grade and survival of women with squamous cell carcinoma of the uterine cervix.肿瘤分化程度与宫颈鳞癌患者生存的关系。
J Gynecol Oncol. 2018 Nov;29(6):e91. doi: 10.3802/jgo.2018.29.e91.
6
Involvement of cancer-derived IgG in the proliferation, migration and invasion of bladder cancer cells.癌症衍生的免疫球蛋白G参与膀胱癌细胞的增殖、迁移和侵袭。
Oncol Lett. 2016 Dec;12(6):5113-5121. doi: 10.3892/ol.2016.5350. Epub 2016 Nov 3.
7
Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up.局部晚期宫颈癌患者接受新辅助化疗+根治性手术+辅助化疗的治疗:单中心10年随访的长期结果、生存率及预后因素
Med Oncol. 2016 Oct;33(10):110. doi: 10.1007/s12032-016-0830-0. Epub 2016 Aug 30.
8
Occult advanced cervical cancer.隐匿性晚期宫颈癌
Br Med J (Clin Res Ed). 1985 May 4;290(6478):1301-2. doi: 10.1136/bmj.290.6478.1301.
9
Young age as a prognostic factor in cervical cancer: analysis of population based data from 10,022 cases.年轻作为宫颈癌的一个预后因素:基于10022例病例的人群数据分析
Br Med J (Clin Res Ed). 1988 Feb 6;296(6619):386-91. doi: 10.1136/bmj.296.6619.386.